BeStock  

Supernus Pharmaceuticals SUPN

US equityMarket cap rank #1870Drug Manufacturers - Specialty & Generic
$28.61 +$0.26 (+0.92%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $28.00 -2.13%
Open$28.39
Prev close$28.35
Day range$28.15 – $29.51
Volume2.83M
Market cap$5.94B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts6
Average target$52.60+83.9% vs. price
  • Buy 83%
  • Hold 17%
Low $37.00Now $28.61Avg $52.60High $87.00

Recent rating changes

The last 20 actions on file set price targets from $37.00 to $87.00, averaging $59.83.

DateFirmRatingTarget
9 Nov 2026 BofA Securities BUY $47.00
4 Nov 2026 Piper Sandler BUY $47.00
4 Nov 2026 Stifel HOLD $37.00
3 Nov 2026 Cantor Fitzgerald BUY $87.00
30 Oct 2026 BofA Securities BUY –
30 Oct 2026 Stifel HOLD $55.00
28 Oct 2026 Barclays BUY $45.00
21 Oct 2026 TD Cowen BUY $65.00
15 Oct 2026 BofA Securities BUY $55.00
12 Oct 2026 BofA Securities BUY $60.00
17 Sep 2026 Craig-Hallum BUY –
3 Aug 2026 TD Cowen BUY $65.00
27 Jul 2026 Piper Sandler BUY $66.00
13 Jul 2026 BofA Securities BUY $63.00
9 Jul 2026 Cantor Fitzgerald BUY $67.00
4 Jun 2026 Piper Sandler BUY $66.00
6 May 2026 Piper Sandler BUY $66.00
6 May 2026 Stifel HOLD $55.00
5 May 2026 TD Cowen BUY $65.00
27 Apr 2026 Piper Sandler BUY $66.00

Discussion

No comments yet — be the first to weigh in on SUPN.

Sign in to join the discussion.

Scroll to Top